Literature DB >> 24515769

Expression and prognostic significance of APE1/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer.

Ambrogio P Londero1, Maria Orsaria, Gianluca Tell, Stefania Marzinotto, Valentina Capodicasa, Mattia Poletto, Carlo Vascotto, Cosimo Sacco, Laura Mariuzzi.   

Abstract

OBJECTIVES: To correlate the expression profile of human apurinic endonuclease/redox factor 1 (APE1/Ref-1) with that of nucleolar/nucleoplasmic protein nucleophosmin 1 (NPM1) in association with the aggressiveness and progression of high-grade ovarian serous cancer.
METHODS: Retrospective study analyzing a tissue microarray of 73 women affected by high-grade ovarian serous cancer. Protein expression was assessed by immunohistochemistry on primary tumor masses and synchronous peritoneal metastases if present.
RESULTS: APE1/Ref-1 and NPM1 showed a significant correlation in ovarian serous cancer. Patients with a poorer outcome showed a significant overexpression of nuclear NPM1 protein. A Cox proportional hazards multivariate regression model revealed NPM1 expression to be independently significant for overall survival in high-grade ovarian serous cancers after correcting for stage, age, cytoreduction completeness, and platinum resistance.
CONCLUSIONS: APE1/Ref-1 interacts with NPM1 to control the DNA damage repair system, and it is likely that this interaction plays a defining role in high-grade ovarian serous carcinoma. A high NPM1 immunohistochemical expression was independently correlated with a shorter survival period and thus appears to be an important prognostic factor.

Entities:  

Keywords:  APE1/Ref-1; NPM1; Ovarian cancer; Prognostic factors; Survival

Mesh:

Substances:

Year:  2014        PMID: 24515769     DOI: 10.1309/AJCPIDKDLSGE26CX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Harutake Sawazaki; Keiichi Ito; Takako Asano; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Kenji Seguchi; Tomohiko Asano
Journal:  World J Urol       Date:  2016-11-24       Impact factor: 4.226

2.  Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.

Authors:  Mattia Poletto; Matilde C Malfatti; Dorjbal Dorjsuren; Pasqualina L Scognamiglio; Daniela Marasco; Carlo Vascotto; Ajit Jadhav; David J Maloney; David M Wilson; Anton Simeonov; Gianluca Tell
Journal:  Mol Carcinog       Date:  2015-04-11       Impact factor: 4.784

Review 3.  The base excision repair process: comparison between higher and lower eukaryotes.

Authors:  Nagham Nafiz Hindi; Noha Elsakrmy; Dindial Ramotar
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

4.  Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.

Authors:  Nur Yucer; Rodney Ahdoot; Michael J Workman; Alexander H Laperle; Maria S Recouvreux; Kathleen Kurowski; Diana J Naboulsi; Victoria Liang; Ying Qu; Jasmine T Plummer; Simon A Gayther; Sandra Orsulic; Beth Y Karlan; Clive N Svendsen
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

5.  Induction of apurinic endonuclease 1 overexpression by endoplasmic reticulum stress in hepatoma cells.

Authors:  Tsung-Lin Cheng; Pin-Shern Chen; Ren-Hao Li; Shyng-Shiou Yuan; Ih-Jen Su; Jui-Hsiang Hung
Journal:  Int J Mol Sci       Date:  2014-07-14       Impact factor: 5.923

Review 6.  Nucleophosmin: from structure and function to disease development.

Authors:  Joseph K Box; Nicolas Paquet; Mark N Adams; Didier Boucher; Emma Bolderson; Kenneth J O'Byrne; Derek J Richard
Journal:  BMC Mol Biol       Date:  2016-08-24       Impact factor: 2.946

7.  APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

Authors:  Chun-Ling Yuan; Fan He; Jia-Zhou Ye; Hui-Ni Wu; Jin-Yan Zhang; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Yan Lin; Rong Liang
Journal:  Oncotarget       Date:  2017-08-02

8.  NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.

Authors:  Luiza Handschuh; Pawel Wojciechowski; Maciej Kazmierczak; Malgorzata Marcinkowska-Swojak; Magdalena Luczak; Krzysztof Lewandowski; Mieczyslaw Komarnicki; Jacek Blazewicz; Marek Figlerowicz; Piotr Kozlowski
Journal:  J Transl Med       Date:  2018-08-20       Impact factor: 5.531

9.  Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.

Authors:  Siying Chen; Hairong He; Yan Wang; Leichao Liu; Yang Liu; Haisheng You; Yalin Dong; Jun Lyu
Journal:  BMC Cancer       Date:  2018-08-20       Impact factor: 4.430

Review 10.  The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.

Authors:  Anna Konopka; Julie D Atkin
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.